Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicine set out in the Schedule hereto:
Schedule
Product: Crestor
Active Ingredient: Rosuvastatin calcium 10.4mg equivalent to 10mg rosuvastatin
Dosage Form: Film coated tablet
New Zealand Sponsor: AstraZeneca Limited
Manufacturers: AstraZeneca GmbH, Plankstadt, Germany
IPR Pharmaceuticals Inc, Canovanas, Puerto Rico
IPR Pharmaceuticals Inc, Carolina, Puerto Rico
Product: Crestor
Active Ingredient: Rosuvastatin calcium 20.8mg equivalent to 20mg rosuvastatin
Dosage Form: Film coated tablet
New Zealand Sponsor: AstraZeneca Limited
Manufacturers: AstraZeneca GmbH, Plankstadt, Germany
IPR Pharmaceuticals Inc, Canovanas, Puerto Rico
IPR Pharmaceuticals Inc, Carolina, Puerto Rico
Product: Crestor
Active Ingredient: Rosuvastatin calcium 41.6mg equivalent to 40mg rosuvastatin
Dosage Form: Film coated tablet
New Zealand Sponsor: AstraZeneca Limited
Manufacturers: AstraZeneca GmbH, Plankstadt, Germany
IPR Pharmaceuticals Inc, Canovanas, Puerto Rico
IPR Pharmaceuticals Inc, Carolina, Puerto Rico
Dated this 23rd day of December 2003.
DON MATHESON, Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on the
6th day of July 2001).